Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 11, 2007, Pages 1283-1292

  Hui, C K ^a   Zhang, H Y ^a   Shek, T ^b   Yao, H ^c   Yueng, Y H ^a   Leung, K W ^a   Lai, S T ^c   Lai, J Y ^c   Leung, N ^d   Lau, G K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

^d ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; BIOPSY; CHINA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 34248597642     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03318.x     Document Type: Article

References (42)

1. EASL. International consensus conference on hepatitis C. J Hepatol 1999 30 : 956 61.
2. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000 20 : 1 16.
3. Seeff L, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion associated non-A, non-B hepatitis. The National Heart, Lung and Blood Institute Study Group. N Engl J Med 1992 327 : 1906 11.
4. Alberti A, Morsica G, Chamello L, et al. Hepatitis C viraemia and liver disease in symptom free individuals with anti-HCV. Lancet 1992 340 : 697 8.
5. Coltorti M, Romano M, Persico M, Morisco F, Tuccillo C, Caporaso N. Hepatitis C virus RNA in serum and liver histology in asymptomatic subjects. Infection 1995 1 : 33 7.
6. Persico M, Persico E, Suozzo R, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000 118 : 760 4.
7. Gholson CF, Morgan K, Catanis G, et al. Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. Am J Gastroenterol 1997 10 : 1788 92.
8. Nutt AK, Hassan HA, Lindsey J, Lamps LW, Raufman JP. Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine transaminase levels. Am J Med 2000 109 : 62 4.
9. EASL. International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999 30 : 956 61.
10. National Institute of Health Consensus Development Conference Statement. Management of Hepatitis C 2002, June 10-12 2002.
11. Booth JC, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut 2001 49 : I1 21.
12. Dhumeaux D, Marcellin P, Lerebours E. Treatment of hepatitis C. The 2002 French consensus. Gut 2003 52 : 1784 7.
13. Hui CK, Belaye T, Montegrande K, Wright TL. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol 2003 38 : 511 7.
14. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997 349 : 825 32.
15. Poynard T, McHutchison J, Manns M, et al Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002 122 : 1303 13.
16. Hui CK, Lau E, Monto A, et al. Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation. Am J Transplant 2006 6 : 1600 8.
17. Hui CK, Lau E, Wu H, et al. Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection. J Clin Virol 2006 35 : 182 92.
18. Hui CK, Cheung WW, Zhang HY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006 131 : 59 68.
19. Hui CK, Sun J, Au WY, et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol 2005 42 : 813 9.
20. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound 1993 21 : 303 8.
21. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001 35 : 421 30.
22. Yu JS, Kim KW, Kim EK, Lee JT, Yoo HS. Contrast enhancement of small hepatocellular carcinoma: usefulness of three successive early image acquisitions during multiphase dynamic MR imaging. AJR Am J Roentgenol 1999 173 : 597 604.
23. Lim JH, Kim CK, Lee WJ, et al. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000 175 : 693 8.
24. Kim T, Murakami T, Takahashi S, et al. Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images. Abdom Imaging 1999 24 : 473 80.
25. Hui CK, Lie A, Au WY, et al. A long-term follow-up study on hepatitis B surface antigen positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 2005 106 : 464 9.
26. Renou C, Halfon P, Pol S, et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 2002 51 : 585 91.
27. Moreno-Otero R, Trapero-Marugan M, Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut 2006 55 : 1055 6.
28. Kyrlagkitsis I, Portmann B, Smith H, O'Grady J, Cramp ME. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol 2003 98 : 1588 93.
29. Ryder SD. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004 53 : 451 5.
30. Cividini A, Rebucci C, Silini E, Mondelli MU. Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign? Gastroenterology 2001 121 : 1526 31.
31. Romeo R, Colombo M, Rumi MG, Soffredini R, Del Ninno E, Donato MF. Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat 1996 3 : 183 90.
32. Sefraty L, Chazouilleres O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996 110 : 291 5.
33. Ideo G, Bellobuono A, Mondazzi L, et al. Alpha interferon treatment in chronic hepatitis C. Clin Exp Rheumatol 1995 13 (Suppl. 13 S167 73.
34. Orito E, Mizokami M, Suzuki K, et al. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment. J Gastroenterol Hepatol 1997 12 : 58 61.
35. Hui CK, Monto A, Belaye T, Lau E, Wright TL. Outcomes of interferon-α and ribavirin treatment for chronic hepatitis C patients with normal serum aminotransaminases. Gut 2003 52 : 1644 8.
36. Zeuzem S, Diago M, Gane E, et al. Peginterferon alfa-2a (40 kDa) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004 127 : 1724 32.
37. Alberti A. Towards more individualized management of hepatitis C virus patients with initially or persistently normal alanine aminotransferase levels. J Hepatol 2005 42 : 266 74.
38. Braunstein H. Needle biopsy of the liver in cirrhosis. Arch Pathol 1956 62 : 87 95.
39. Waldstein SS, Szanto PB. Accuracy of sampling by needle biopsy in diffuse liver disease. Arch Pathol 1950 50 : 326 8.
40. Hubscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998 29 : 1015 22.
41. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 128 : 343 50.
42. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006 55 : 403 8.